Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie A Cesaretti

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Brachytherapy|July 19, 2008
Distant and local recurrence in patients with biochemical failure after prostate brachytherapyRichard G Stock, Jamie A Cesaretti, Pamela Unger, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2008
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapyAmy N Solan, Jamie A Cesaretti, Nelson N Stone, et al.
BJU International|June 5, 2009
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapyRichard G Stock, Jamie A Cesaretti, Simon J Hall, et al.
Brachytherapy|February 8, 2007
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFSTimothy M Zagar, Richard G Stock, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy resultsRichard G Stock, Nelson N Stone, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel diseaseChristopher A Peters, Jamie A Cesaretti, Nelson N Stone, et al.
Cancer|December 14, 2007
Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinomaAmir Lavaf, Eric M Genden, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapyRichard G Stock, Thomas J Klein, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Combined modality treatment in the management of high-risk prostate cancerRichard G Stock, Oren Cahlon, Jamie A Cesaretti, et al.
The Annals of Thoracic Surgery|January 29, 2008
Stereotactic radiosurgery for thoracic malignanciesJamie A Cesaretti, Arjun Pennathur, Barry S Rosenstein, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Brachytherapy|July 19, 2008
Distant and local recurrence in patients with biochemical failure after prostate brachytherapyRichard G Stock, Jamie A Cesaretti, Pamela Unger, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2008
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapyAmy N Solan, Jamie A Cesaretti, Nelson N Stone, et al.
BJU International|June 5, 2009
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapyRichard G Stock, Jamie A Cesaretti, Simon J Hall, et al.
Brachytherapy|February 8, 2007
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFSTimothy M Zagar, Richard G Stock, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy resultsRichard G Stock, Nelson N Stone, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel diseaseChristopher A Peters, Jamie A Cesaretti, Nelson N Stone, et al.
Cancer|December 14, 2007
Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinomaAmir Lavaf, Eric M Genden, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2008
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapyRichard G Stock, Thomas J Klein, Jamie A Cesaretti, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Combined modality treatment in the management of high-risk prostate cancerRichard G Stock, Oren Cahlon, Jamie A Cesaretti, et al.
The Annals of Thoracic Surgery|January 29, 2008
Stereotactic radiosurgery for thoracic malignanciesJamie A Cesaretti, Arjun Pennathur, Barry S Rosenstein, et al.
Pageof 4